Nessan Bermingham Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nessan Bermingham.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nessan Bermingham. Nessan Bermingham is a Director in F-star Therapeutics, Inc. ($SBPH) and a President & CEO in Intellia Therapeutics, Inc. ($NTLA).
Address: C/O INTELLIA THERAPEUTICS, INC. 130 BROOKLINE STREET, SUITE 201 CAMBRIDGE 02139 MA
Companies in which Nessan Bermingham is an Insider
F-star Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nessan Bermingham: Director
Holdings: 103,875 shares
Current Value: $779,063
Latest Transaction: Feb 02 2021
$SBPH Market Capitalization: $58.25M
$SBPH Previous Close: $7.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intellia Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Nessan Bermingham: President & CEO
Holdings: 696,000 shares
Current Value: $9,256,800
Latest Transaction: Dec 14 2017
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Nessan Bermingham
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 02 2021 | SBPH | F-star Therapeutic ... | Bermingham Nessan | Director | Grant | A | 0.00 | 87,000 | 0 | 103,875 | 16.9 K to 103.9 K (+515.56 %) |
| Dec 14 2017 | NTLA | Intellia Therapeut ... | Bermingham Nessan | President & CEO | Option Exercise | A | 18.30 | 292,500 | 5,351,288 | 292,500 | |
| Dec 08 2017 | NTLA | Intellia Therapeut ... | Bermingham Nessan | President & CEO | Sell | S | 20.82 | 94,143 | 1,960,151 | 458,250 | 552.4 K to 458.3 K (-17.04 %) |
| Dec 08 2017 | NTLA | Intellia Therapeut ... | Bermingham Nessan | President & CEO | Sell | S | 21.46 | 27,566 | 591,489 | 552,393 | 580 K to 552.4 K (-4.75 %) |
| Dec 08 2017 | NTLA | Intellia Therapeut ... | Bermingham Nessan | President & CEO | Sell | S | 21.05 | 103,574 | 2,180,378 | 579,959 | 683.5 K to 580 K (-15.15 %) |
| Dec 08 2017 | NTLA | Intellia Therapeut ... | Bermingham Nessan | President & CEO | Sell | S | 20.84 | 12,467 | 259,810 | 683,533 | 696 K to 683.5 K (-1.79 %) |
| Dec 08 2017 | NTLA | Intellia Therapeut ... | Bermingham Nessan | President & CEO | Sell | S | 20.28 | 99,033 | 2,008,191 | 696,000 | 795 K to 696 K (-12.46 %) |